NAT14 Antikörper (N-Term)
-
- Target Alle NAT14 Antikörper anzeigen
- NAT14 (N-Acetyltransferase 14 (GCN5-Related, Putative) (NAT14))
-
Bindungsspezifität
- AA 5-33, N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser NAT14 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC)
- Verwendungszweck
- Rabbit Anti-Human NAT14 (N-term) Antibody
- Immunogen
- This NAT14 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 5-33 amino acids from the N-terminal region of human NAT14.
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product NAT14 Primärantikörper
-
-
- Applikationshinweise
-
Western Blot, Immunohistochemistry
Recommended Dilutions
WB: 1:1000, IHC: 1:50-100Western blot analysis of lysate from K562 cell line, using NAT14 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- 2-8°C (short-term), -20°C (long-term)
-
- Target
- NAT14 (N-Acetyltransferase 14 (GCN5-Related, Putative) (NAT14))
- Andere Bezeichnung
- NAT14 (NAT14 Produkte)
- Synonyme
- BC047219 antikoerper, KLP1 antikoerper, N-acetyltransferase 14 antikoerper, N-acetyltransferase 14 (putative) antikoerper, Nat14 antikoerper, NAT14 antikoerper
- Hintergrund
-
Gene Symbol: NAT14
- Molekulargewicht
- 21650 Da
- Gen-ID
- 57106
- UniProt
- Q8WUY8
- Pathways
- SARS-CoV-2 Protein Interaktom
-